In-silico pharmaceutics: Quantum simulations for next-generation dosage form design
Abstract
In-silico pharmaceutics employs computational models and simulations to predict the behavior of pharmaceutical formulations, thereby optimizing drug development workflows. This approach significantly reduces the time, cost, and ethical concerns associated with extensive physical experiments and animal testing. Key methodologies include molecular docking and dynamics for evaluating drug-excipient interactions, Physiologically Based Pharmacokinetic (PBPK) modeling for systemic drug behavior prediction, and Computational Fluid Dynamics (CFD) for process optimization. Furthermore, Artificial Intelligence and Machine Learning models enable rapid screening of formulation variables, while digital twins provide real-time monitoring and predictive control of manufacturing processes. The integration of these tools with quantum simulations promises enhanced accuracy and speed in molecular design. Future perspectives center on the democratization of advanced computational power via cloud-based quantum platforms and the convergence with multi-omics data, paving the way for data-driven, personalized drug development.
How strong is the evidence?
Evidence Hub reads this as a simulation / modelling, done in computer models (in silico), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Chaos and quantum thermalization
- The Dalton quantum chemistry program system
- Cord Blood Leptin and Adiponectin as Predictors of Adiposity in Children at 3 Years of Age: A Prospective Cohort Study
- Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes
- Stable adiabatic quantum batteries
- A novel self-lipid antigen targets human T cells against CD1c(+) leukemias
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.